Terminally ill patients left Medicare Advantage for traditional Medicare at double the rate of other enrollees from 2016 to ...

The lawsuit, filed in a Maryland state court in late February, alleges that the UnitedHealth Group subsidiary's cybersecurity standards were insufficient to prevent the attack. The Russian ransomware ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

We recently published a list of 10 Most Undervalued High Quality Stocks to Buy According to Analysts. In this article, we are ...

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on March 06th, the Representative disclosed that they ...

Investment analysts at Zacks Research increased their Q1 2025 earnings estimates for shares of UnitedHealth Group in a report released on Thursday, March 6th. Zacks Research analyst D. Chatterjee now ...

Just over a year ago, cybercriminals launched a ransomware attack on clearinghouse Change Healthcare in what became the ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

UnitedHealth acquired or created 250 subsidiaries in 2024 as it pursues an ambitious vertical integration strategy.

Daytime television inundates American seniors with advertisements for UnitedHealthcare’s (“UHC”) Medicare Advantage Plans. On its website, UHC ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Inc. (UNH), SAP SE ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...